Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 6,200 shares at $409.40 ($2.5M) on 2021-08-06, disclosed to the SEC on 2021-08-10.
Open-market sale of $2.5M CRL by EVP, Corporate Strategy & Develop. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $400.91 | 1,458 | $585K | 23.5% |
| 2 | $400.91 | 1,458 | $585K | 23.5% |
| 3 | $401.66 | 900 | $361K | 14.5% |
| 4 | $402.43 | 1,042 | $419K | 16.8% |
| 5 | $402.43 | 1,042 | $419K | 16.8% |
| 6 | $409.40 | 300 |
| $123K |
| 4.9% |
| Total | $401.94 avg | 6,200 | $2.5M | 100% |
| Filing → |
| CRL | SELL | 2025-08-20 | $126K | — | Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |